Clinical Trials Directory

Trials / Completed

CompletedNCT03963323

Glucosamine and Chondroitin in Gut in Preventing People From Inflammation

GLANCE2.1 - Glucosamine and Chondroitin (G&C) Effects Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Fred Hutchinson Cancer Center · Academic / Other
Sex
All
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

This trial studies glucosamine and chondroitin in preventing inflammation. Glucosamine and chondroitin often used as a dietary supplement to promote joint health may have a preventive role in inflammation and cancer. This trial may help identify the bacteria that help process them in the gut.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGlucosamine Sulfate/Chondroitin Sulfate TabletGiven PO
OTHERPlaceboGiven PO

Timeline

Start date
2018-05-11
Primary completion
2019-03-31
Completion
2019-03-31
First posted
2019-05-24
Last updated
2019-05-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03963323. Inclusion in this directory is not an endorsement.